USPTO serial 76333307
PRO-DRY-X
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- THOMPSON, LAVERNE
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with PRO-DRY-X?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
HAL E BORDEN
HAL E BORDEN DECHERT LLP4000 BELL ATLANTIC TWR1717 ARCH STPHILADELPHIA, PA 19103-2793Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 007 | Manufacturing equipment, namely, machines used in researching, developing and manufacturing pharmaceuticals, nutraceuticals, chemicals, proteins, peptides, oligonucleotides, DNA, vaccines, other biotechnology-derived products, and other products using supercritical fluid technology | ACTIVE | — |
| 009 | Laboratory equipment for use in researching, developing and manufacturing pharmaceuticals, nutraceuticals, chemicals, proteins, peptides, oligonucleotides, DNA, vaccines, other biotechnology-derived products, and other products using supercritical fluid technology | ACTIVE | — |
| 040 | Custom manufacturing of pharmaceuticals, nutraceuticals, chemicals, proteins, peptides, oligonucleotides, DNA, vaccines, other biotechnology-derived products, and other products using supercritical fluid technology | ACTIVE | — |
| 042 | Conducting feasibility studies for others on the use of supercritical fluids in the formulation of pharmaceuticals, nutraceuticals, chemicals, proteins, peptides, oligonucleotides, DNA, vaccines, other biotechnology-derived products, and other products; licensing of supercritical fluid technology; developing pharmaceuticals, nutraceuticals, chemicals, proteins, peptides, oligonucleotides, DNA, vaccines, other biotechnology-derived products, and other products for others using supercritical fluid technology | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by LAVIPHARM LABORATORIES INC.
- Other trademarks owned by LAVIPHARM LABORATORIES INC.
- Other trademarks in Class 007
- Other trademarks in Class 009
- Other trademarks in Class 040
- Other trademarks in Class 042
- Similar marks named PRO-DRY-X
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 27, 2005 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Sep 27, 2005 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Oct 5, 2004 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Sep 15, 2004 | EXT2 | SOU EXTENSION 2 FILED | — |
| Sep 15, 2004 | PAPER RECEIVED | — | |
| Sep 9, 2004 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Sep 7, 2004 | PETG | PETITION TO REVIVE-GRANTED | — |
| May 12, 2004 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Apr 21, 2004 | CFIT | CASE FILE IN TICRS | — |
| Apr 9, 2004 | PETR | PETITION TO REVIVE-RECEIVED | — |
| Apr 9, 2004 | PAPER RECEIVED | — | |
| Apr 7, 2004 | EXT1 | SOU EXTENSION 1 FILED | — |
| Oct 7, 2003 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jul 15, 2003 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 25, 2003 | NPUB | NOTICE OF PUBLICATION | — |
| May 1, 2003 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 26, 2003 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 26, 2003 | PAPER RECEIVED | — | |
| Mar 24, 2003 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 24, 2002 | CNFR | FINAL REFUSAL MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jul 31, 2002 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 31, 2002 | PAPER RECEIVED | — | |
| Jul 29, 2002 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 29, 2002 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 25, 2002 | DOCK | ASSIGNED TO EXAMINER | — |